162 related articles for article (PubMed ID: 8971929)
1. BW 1023U90: a new GRP receptor antagonist for small-cell lung cancer cells.
Moody TW; Venugopal R; Hu V; Gozes Y; McDermed J; Leban JJ
Peptides; 1996; 17(8):1337-43. PubMed ID: 8971929
[TBL] [Abstract][Full Text] [Related]
2. BW2258U89: a GRP receptor antagonist which inhibits small cell lung cancer growth.
Moody TW; Venugopal R; Zia F; Patierno S; Leban JJ; McDermed J
Life Sci; 1995; 56(7):521-9. PubMed ID: 7869832
[TBL] [Abstract][Full Text] [Related]
3. Effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonists on the growth of human small-cell and non-small-cell lung carcinomas in nude mice.
Pinski J; Schally AV; Halmos G; Szepeshazi K; Groot K; O'Byrne K; Cai RZ
Br J Cancer; 1994 Nov; 70(5):886-92. PubMed ID: 7947094
[TBL] [Abstract][Full Text] [Related]
4. Reduction in receptors for bombesin and epidermal growth factor in xenografts of human small-cell lung cancer after treatment with bombesin antagonist RC-3095.
Halmos G; Schally AV
Proc Natl Acad Sci U S A; 1997 Feb; 94(3):956-60. PubMed ID: 9023364
[TBL] [Abstract][Full Text] [Related]
5. [Psi 13,14] bombesin analogues inhibit growth of small cell lung cancerin vitro and in vivo.
Mahmoud S; Staley J; Taylor J; Bogden A; Moreau JP; Coy D; Avis I; Cuttitta F; Mulshine JL; Moody TW
Cancer Res; 1991 Apr; 51(7):1798-802. PubMed ID: 1848479
[TBL] [Abstract][Full Text] [Related]
6. The metabolism of BW2258U89, a GRP receptor antagonist.
Marquez C; Treston A; Moody E; Jakowlew S; Moody TW
Neuropeptides; 2000 Apr; 34(2):108-15. PubMed ID: 10985927
[TBL] [Abstract][Full Text] [Related]
7. New short-chain analogs of a substance-P antagonist inhibit proliferation of human small-cell lung-cancer cells in vitro and in vivo.
Orosz A; Schrett J; Nagy J; Bartha L; Schön I; Nyéki O
Int J Cancer; 1995 Jan; 60(1):82-7. PubMed ID: 7529212
[TBL] [Abstract][Full Text] [Related]
8. Neuromedin B binds with high affinity, elevates cytosolic calcium and stimulates the growth of small-cell lung cancer cell lines.
Moody TW; Staley J; Zia F; Coy DH; Jensen RT
J Pharmacol Exp Ther; 1992 Oct; 263(1):311-7. PubMed ID: 1328611
[TBL] [Abstract][Full Text] [Related]
9. Correlation of expression of bombesin-like peptides and receptors with growth inhibition by an anti-bombesin antibody in small-cell lung cancer cell lines.
Yang HK; Scott FM; Trepel JB; Battey JF; Johnson BE; Kelley MJ
Lung Cancer; 1998 Sep; 21(3):165-75. PubMed ID: 9857994
[TBL] [Abstract][Full Text] [Related]
10. Metabolic stability and tumor inhibition of bombesin/GRP receptor antagonists.
Davis TP; Crowell S; Taylor J; Clark DL; Coy D; Staley J; Moody TW
Peptides; 1992; 13(2):401-7. PubMed ID: 1329046
[TBL] [Abstract][Full Text] [Related]
11. High affinity receptors for bombesin/GRP-like peptides on human small cell lung cancer.
Moody TW; Carney DN; Cuttitta F; Quattrocchi K; Minna JD
Life Sci; 1985 Jul; 37(2):105-13. PubMed ID: 2409423
[TBL] [Abstract][Full Text] [Related]
12. The release of bombesin-like peptides from small cell lung cancer cells.
Moody TW; Korman LY
Ann N Y Acad Sci; 1988; 547():351-9. PubMed ID: 2853597
[TBL] [Abstract][Full Text] [Related]
13. Bombesin/gastrin-releasing peptide antagonists RC-3095 and RC-3940-II inhibit tumor growth and decrease the levels and mRNA expression of epidermal growth factor receptors in H-69 small cell lung carcinoma.
Koppán M; Halmos G; Arencibia JM; Lamharzi N; Schally AV
Cancer; 1998 Oct; 83(7):1335-43. PubMed ID: 9762934
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of proliferation of human small cell lung cancer cells expressing an autocrine system for gastrin releasing peptide by antisense oligodeoxynucleotides to gastrin releasing peptide receptor.
Langer DA; Kautzman D; Kane MA
Lung Cancer; 2002 Jun; 36(3):235-42. PubMed ID: 12009231
[TBL] [Abstract][Full Text] [Related]
15. Antitumoral activity of bombesin analogues on small cell lung cancer xenografts: relationship with bombesin receptor expression.
Thomas F; Arvelo F; Antoine E; Jacrot M; Poupon MF
Cancer Res; 1992 Sep; 52(18):4872-7. PubMed ID: 1325285
[TBL] [Abstract][Full Text] [Related]
16. Characterization of ligand binding and processing by gastrin-releasing peptide receptors in a small-cell lung cancer cell line.
Cardona C; Bleehen NM; Reeve JG
Biochem J; 1992 Jan; 281 ( Pt 1)(Pt 1):115-20. PubMed ID: 1310003
[TBL] [Abstract][Full Text] [Related]
17. Bombesin stimulates c-fos and c-jun mRNAs in small cell lung cancer cells.
Draoui M; Chung P; Park M; Birrer M; Jakowlew S; Moody TW
Peptides; 1995; 16(2):289-92. PubMed ID: 7784258
[TBL] [Abstract][Full Text] [Related]
18. Evidence for autocrine actions of neuromedin B and gastrin-releasing peptide in non-small cell lung cancer.
Siegfried JM; Krishnamachary N; Gaither Davis A; Gubish C; Hunt JD; Shriver SP
Pulm Pharmacol Ther; 1999; 12(5):291-302. PubMed ID: 10545285
[TBL] [Abstract][Full Text] [Related]
19. Effects of bombesin on human small cell lung cancer cells: evidence for a subset of bombesin non-responsive cell lines.
Kado-Fong H; Malfroy B
J Cell Biochem; 1989 Aug; 40(4):431-7. PubMed ID: 2550492
[TBL] [Abstract][Full Text] [Related]
20. Bombesin/gastrin-releasing peptide receptor: a potential target for antibody-mediated therapy of small cell lung cancer.
Zhou J; Chen J; Mokotoff M; Zhong R; Shultz LD; Ball ED
Clin Cancer Res; 2003 Oct; 9(13):4953-60. PubMed ID: 14581370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
